| ISIN | LU2492015610 |
|---|---|
| Valorennummer | 120608809 |
| Bloomberg Global ID | |
| Fondsname | Kieger Sustainable Healthcare Fund Class A CHF (H) Accumulating |
| Fondsanbieter |
Kieger AG
Kieger AG Limmatstrasse 264, CH-8005 Zürich Telefon: +41 44 444 18 44 Web: https://kieger.com/ E-Mail: info@kieger.com |
| Fondsanbieter | Kieger AG |
| Vertreter in der Schweiz |
ACOLIN Fund Services AG Zürich Telefon: +41 44 396 96 96 |
| Distributor(en) | |
| Anlagekategorie | Aktienfonds |
| EFC-Kategorie | |
| Anteilskategorie | Accumulation |
| Domizilland | Luxemburg |
| Konditionen bei der Ausgabe | keine Ausgabekommission und/oder Gebühren zugunsten des Fonds (Ausgabe erfolgt zum Inventarwert) |
| Konditionen bei der Rücknahme | Keine Rücknahmekommission und/oder Gebühren zugunsten des Fonds (Rücknahme erfolgt zum Inventarwert) |
| Investment-Strategie *** | The investment objective of the Sub-Fund is to achieve long term capital growth by principally investing in equities of healthcare and healthcare related issuers worldwide (including Emerging Markets). The Sub-Fund aims to have a positive impact on society by investing in sustainable companies with current or future activities positively contributing to good health and well-being. The objective is reached by investing in innovative companies with differentiated products and/or services that are leaders in sustainability as identified through a proprietary sustainability framework developed by the Investment Manager. |
| Besonderheiten |
| Aktueller Preis * | 99.21 CHF | 17.11.2025 |
|---|---|---|
| Vorheriger Preis * | 99.65 CHF | 14.11.2025 |
| 52 Wochen Hoch * | 104.77 CHF | 05.02.2025 |
| 52 Wochen Tief * | 89.41 CHF | 07.08.2025 |
| NAV * | 99.21 CHF | 17.11.2025 |
| Ausgabepreis * | ||
| Rücknahmepreis * | ||
| Schlusskurs * | ||
| Indikativer Minimalpreis | ||
| Fondsvermögen *** | 179'072'235 | |
| Anteilsklassevermögen *** | 1'039'984 | |
| Trading Information SIX | ||
| YTD-Performance | +2.41% |
31.12.2024 - 17.11.2025
31.12.2024 17.11.2025 |
|---|---|---|
| 1 Monat | +2.78% |
17.10.2025 - 17.11.2025
17.10.2025 17.11.2025 |
| 3 Monate | +5.61% |
18.08.2025 - 17.11.2025
18.08.2025 17.11.2025 |
| 6 Monate | +3.68% |
19.05.2025 - 17.11.2025
19.05.2025 17.11.2025 |
| 1 Jahr | -1.40% |
18.11.2024 - 17.11.2025
18.11.2024 17.11.2025 |
| 2 Jahre | +5.53% |
17.11.2023 - 17.11.2025
17.11.2023 17.11.2025 |
| 3 Jahre | +3.15% |
17.11.2022 - 17.11.2025
17.11.2022 17.11.2025 |
| 5 Jahre | -0.79% |
04.08.2022 - 17.11.2025
04.08.2022 17.11.2025 |
| Kapitalbeteiligungsquote in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Anteil am Gesamtvermögen in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Immobilienquote in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI Date | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Eli Lilly and Co | 6.00% | |
|---|---|---|
| AstraZeneca PLC | 5.92% | |
| Abbott Laboratories | 5.59% | |
| Novartis AG Registered Shares | 5.45% | |
| Roche Holding AG | 5.29% | |
| UnitedHealth Group Inc | 4.40% | |
| Boston Scientific Corp | 4.27% | |
| Novo Nordisk AS Class B | 3.61% | |
| Danaher Corp | 3.51% | |
| Stryker Corp | 3.30% | |
| Letzte Daten-Aktualisierung | 31.08.2025 | |
| TER | |
|---|---|
| Datum TER | |
| Performance Fee *** | |
| PTR | |
| Max. Management Fee *** | 0.85% |
| Ongoing Charges *** | 1.34% |
|
SRRI ***
|
|
| Datum SRRI *** | 30.04.2024 |